Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Int J Rheum Dis ; 17(4): 471-5, 2014 May.
Article in English | MEDLINE | ID: mdl-24460826

ABSTRACT

Here, we present a young male patient who was admitted with alveolar hemorrhage, arthritis and cutaneous lesions, who later developed bilateral orbital involvement and pyoderma gangrenosum (PG). He also had pathergy test positivity. The patient was refractory to conventional immunosuppressive therapy. Therefore, multiple devastating PG lesions and disease activity in granulomatosis with polyangiitis (GPA) were controlled with infliximab. Later, rituximab was used with success to prevent recurrence of symptoms. The relationship of PG with various autoimmune diseases is known; however, PG in GPA has been only rarely reported. Biologic agents might prove to be effective in GPA and PG patients who are refractory to standard immunosuppressive therapy.


Subject(s)
Antibodies, Monoclonal, Murine-Derived/therapeutic use , Antibodies, Monoclonal/therapeutic use , Granulomatosis with Polyangiitis/drug therapy , Immunosuppressive Agents/therapeutic use , Pyoderma Gangrenosum/drug therapy , Adult , Drug Therapy, Combination , Granulomatosis with Polyangiitis/blood , Granulomatosis with Polyangiitis/diagnosis , Granulomatosis with Polyangiitis/immunology , Humans , Infliximab , Male , Pyoderma Gangrenosum/blood , Pyoderma Gangrenosum/diagnosis , Pyoderma Gangrenosum/immunology , Rituximab , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL
...